These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 37467476)
1. Tales from the future-nuclear cardio-oncology, from prediction to diagnosis and monitoring. Mikail N; Chequer R; Imperiale A; Meisel A; Bengs S; Portmann A; Gimelli A; Buechel RR; Gebhard C; Rossi A Eur Heart J Cardiovasc Imaging; 2023 Aug; 24(9):1129-1145. PubMed ID: 37467476 [TBL] [Abstract][Full Text] [Related]
2. Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology. Gambril JA; Chum A; Goyal A; Ruz P; Mikrut K; Simonetti O; Dholiya H; Patel B; Addison D Heart Fail Clin; 2022 Jul; 18(3):455-478. PubMed ID: 35718419 [TBL] [Abstract][Full Text] [Related]
3. Advanced Echocardiographic Techniques in Cardio-Oncology: the Role for Early Detection of Cardiotoxicity. Cobarro Gálvez L; Arbas Redondo E; Contreras Lorenzo C; López Fernández T Curr Cardiol Rep; 2022 Sep; 24(9):1109-1116. PubMed ID: 35881319 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology. Pepe A; Pizzino F; Gargiulo P; Perrone-Filardi P; Cadeddu C; Mele D; Monte I; Novo G; Zito C; Di Bella G J Cardiovasc Med (Hagerstown); 2016 May; 17 Suppl 1():e45-e54. PubMed ID: 27183525 [TBL] [Abstract][Full Text] [Related]
5. Role of cardiovascular magnetic resonance imaging in cardio-oncology. Saunderson CED; Plein S; Manisty CH Eur Heart J Cardiovasc Imaging; 2021 Mar; 22(4):383-396. PubMed ID: 33404058 [TBL] [Abstract][Full Text] [Related]
6. [Role of echocardiography in the detection and the monitoring of left ventricular systolic dysfunction in patients undergoing cancer therapy]. Charbonnel C Ann Cardiol Angeiol (Paris); 2020 Nov; 69(5):255-261. PubMed ID: 32962803 [TBL] [Abstract][Full Text] [Related]
7. The Role of Cardiovascular Magnetic Resonance for Surveillance of Cardiac Performance upon Receipt of Potentially Cardiotoxic Cancer Therapeutics. Parashar A; Hundley WG Curr Cardiol Rep; 2018 Oct; 20(12):142. PubMed ID: 30367282 [TBL] [Abstract][Full Text] [Related]
8. Shining Damaged Hearts: Immunotherapy-Related Cardiotoxicity in the Spotlight of Nuclear Cardiology. Kersting D; Settelmeier S; Mavroeidi IA; Herrmann K; Seifert R; Rischpler C Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409161 [TBL] [Abstract][Full Text] [Related]
9. Cardio-Oncology for the Primary Care Provider. Jhawar N; Mcpherson A; Chirila R; Ray J Rom J Intern Med; 2023 Sep; 61(3):127-134. PubMed ID: 37249550 [TBL] [Abstract][Full Text] [Related]
10. What Does a Cardio-oncology Service Offer to the Oncologist and the Haematologist? Andres MS; Pan J; Lyon AR Clin Oncol (R Coll Radiol); 2021 Aug; 33(8):483-493. PubMed ID: 33832839 [TBL] [Abstract][Full Text] [Related]
11. Cardio-oncology: the role of advanced echocardiography in cancer patients. Venneri L; Zoppellaro G; Khattar RS Expert Rev Cardiovasc Ther; 2018 Apr; 16(4):249-258. PubMed ID: 29457984 [TBL] [Abstract][Full Text] [Related]
12. Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management. Curigliano G; Cardinale D; Dent S; Criscitiello C; Aseyev O; Lenihan D; Cipolla CM CA Cancer J Clin; 2016 Jul; 66(4):309-25. PubMed ID: 26919165 [TBL] [Abstract][Full Text] [Related]
13. The Role of Multimodality Cardiac Imaging in Patients Undergoing Cancer Treatment. Wengrofsky P; Feldman S Curr Cardiol Rep; 2023 Jan; 25(1):1-8. PubMed ID: 36527535 [TBL] [Abstract][Full Text] [Related]
14. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Totzeck M; Aide N; Bauersachs J; Bucerius J; Georgoulias P; Herrmann K; Hyafil F; Kunikowska J; Lubberink M; Nappi C; Rassaf T; Saraste A; Sciagra R; Slart RHJA; Verberne H; Rischpler C Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):792-812. PubMed ID: 36334105 [TBL] [Abstract][Full Text] [Related]
15. Role of cardiovascular imaging in cancer patients receiving cardiotoxic therapies: a position statement on behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC). Čelutkienė J; Pudil R; López-Fernández T; Grapsa J; Nihoyannopoulos P; Bergler-Klein J; Cohen-Solal A; Farmakis D; Tocchetti CG; von Haehling S; Barberis V; Flachskampf FA; Čeponienė I; Haegler-Laube E; Suter T; Lapinskas T; Prasad S; de Boer RA; Wechalekar K; Anker MS; Iakobishvili Z; Bucciarelli-Ducci C; Schulz-Menger J; Cosyns B; Gaemperli O; Belenkov Y; Hulot JS; Galderisi M; Lancellotti P; Bax J; Marwick TH; Chioncel O; Jaarsma T; Mullens W; Piepoli M; Thum T; Heymans S; Mueller C; Moura B; Ruschitzka F; Zamorano JL; Rosano G; Coats AJS; Asteggiano R; Seferovic P; Edvardsen T; Lyon AR Eur J Heart Fail; 2020 Sep; 22(9):1504-1524. PubMed ID: 32621569 [TBL] [Abstract][Full Text] [Related]
18. Cardio-Oncology in Childhood: State of the Art. Bennati E; Girolami F; Spaziani G; Calabri GB; Favre C; Parrini I; Lucà F; Tamburini A; Favilli S Curr Oncol Rep; 2022 Dec; 24(12):1765-1777. PubMed ID: 36181610 [TBL] [Abstract][Full Text] [Related]
19. The Role of CYP450 Drug Metabolism in Precision Cardio-Oncology. Fatunde OA; Brown SA Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963461 [TBL] [Abstract][Full Text] [Related]